SCHEMBL7852032

SCHEMBL7852032

CCC(Oc1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-])N1CCNCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 3/20 0.67
▸ EGFR P00533 18/20 0.64
▸ ERBB2 P04626 3/20 0.51
▸ ERBB4 Q15303 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.49
▸ GAK O14976 1/20 0.49
▸ MAPK13 O15264 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CDK1 P06493 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ SRC P12931 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ EPHB2 P29323 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ KDR P35968 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995000 0.91 FBP1 (0.67) FBP1EGFRERBB2ERBB4KDM4E
SCHEMBL1418418 0.83 FBP1 (0.68) FBP1EGFR
SCHEMBL2985880 0.82 FBP1 (0.54) FBP1EGFRSRCKDRABCG2
SCHEMBL1418195 0.82 FBP1 (0.67) FBP1EGFRERBB2
SCHEMBL1417914 0.79 FBP1 (0.70) FBP1EGFRERBB2ERBB4KDM4E
SCHEMBL1418282 0.79 EGFR (0.69) FBP1EGFRERBB2ERBB4KDM4E
SCHEMBL17940088 0.79 EGFR (1.00) FBP1EGFRERBB2ERBB4KDM4E
SCHEMBL1417871 0.78 FBP1 (0.68) FBP1EGFRKDR
SCHEMBL1418046 0.77 FBP1 (0.67) FBP1EGFRKDR
SCHEMBL7849884 0.77 FBP1 (0.60) FBP1EGFRERBB2ERBB4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157011-A1 4-AMINO- QUINAZOLINE AND QUINOLINE DERIVATIVES HAVING AN INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES Boehringer Ingelheim Pharma KG (DE) 2001-11-28 — — EP disclosed
WO-2000051991-A1 4-AMINO-QUINAZOLINE AND QUINOLINE DERIVATIVES HAVING AN INHIBITORY EFFECT ON SIGNAL TRANsSDUCTION MEDIATED BY TYROSINE KINASES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-08 — — WO disclosed
Send feedback